We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CRIS market cap is 45.97M. The company's latest EPS is USD -8.0442 and P/E is -0.97.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.3M | 2.2M | 2.83M | 2.7M | 2.09M |
| Operating Income | -11.63M | -12.14M | -12.37M | -12.2M | -12.47M |
| Net Income | -11.56M | -11.96M | -12.18M | -11.71M | -11.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10M | 10.84M | 10.65M | 10.16M | 10.02M |
| Operating Income | -24.36M | -24.9M | -42.07M | -53.02M | -48.33M |
| Net Income | -32.14M | -29.91M | -45.44M | -56.67M | -47.41M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 94.54M | 84.31M | 89.98M | 77.28M | 62.02M |
| Total Liabilities | 57.95M | 58.08M | 60.38M | 57.61M | 52.56M |
| Total Equity | 36.59M | 26.22M | 29.59M | 19.67M | 9.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 35.11M | 204.36M | 162.3M | 108.85M | 77.28M |
| Total Liabilities | 69.02M | 73.69M | 71.59M | 62.3M | 57.61M |
| Total Equity | -33.91M | 130.67M | 90.71M | 46.55M | 19.67M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.2M | -20.07M | -28.25M | -38.43M | -13.23M |
| Investing | 26.24M | 23.09M | 23.27M | 37.79M | 18.91M |
| Financing | -2.01M | -2.86M | 9.7M | 7.58M | -2.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.21M | -25.74M | -37.62M | -54.34M | -38.43M |
| Investing | -4.46M | -49.05M | -47.9M | 33.02M | 37.79M |
| Financing | 23.27M | 171.31M | -4.17M | 867k | 7.58M |
| Market Cap | 45.97M |
| Price to Earnings Ratio | -0.97 |
| Price to Sales Ratio | 4.59 |
| Price to Cash Ratio | 1.72 |
| Price to Book Ratio | 2.34 |
| Dividend Yield | - |
| Shares Outstanding | 5.89M |
| Average Volume (1 week) | 21.97k |
| Average Volume (1 Month) | 32.98k |
| 52 Week Change | -50.00% |
| 52 Week High | 18.00 |
| 52 Week Low | 3.80 |
| Spread (Intraday) | 1.08 (12.51%) |
| Company Name | Curis Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.curis.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
